Skip to content

Mapping Non-Prescription Pre-Session Support across Psychedelic Substances

Elias Rubenstein

International Journal of Independent Research Studies May 21, 2026 Peer reviewed DOI: 10.55220/2304-6953.v15i3.946 via OpenAlex

Summary

The article categorizes non-prescription pre-session supports used before psychedelic sessions, such as nutrients and acupoint stimulation, into a research taxonomy. These practices are often presented as informal advice rather than formal research categories. The aim is to document and compare these supports for future research without making clinical recommendations or proposing specific supplement stacks. Individual agents are discussed only as examples within broader categories.

Study at a glance

Key finding Non-prescription pre-session support practices for psychedelics are organized into a research taxonomy to facilitate future documentation and comparison.

Abstract

Psychedelic preparation is commonly discussed through screening, psychological readiness, set, setting, therapeutic support, and integration planning. In clinical-adjacent, retreat, ceremonial, and harm-reduction contexts, however, non-prescription pre-session supports are also used or discussed before psychedelic sessions. These practices may involve nutrients, botanicals, amino acids, cannabinoids, terpenes, hydration strategies, sleep-related agents, gastrointestinal supports, or non-ingestive procedures such as PC6 acupoint stimulation and orientation scripts. At present, they are often described as informal advice, product-specific recommendations, or commercial stacks rather than as researchable categories. This article maps non-prescription pre-session support practices across psychedelic substances and organizes them into a research taxonomy based on intended target domain, inclusion rationale, psychedelic context, evidence boundary, and interaction burden. It does not propose supplement stacks, dosing rules, treatment recommendations, medication-discontinuation advice, or clinical protocols. Individual agents are mentioned only as illustrative examples of broader categories and are linked to evidence boundaries. The purpose is to make such practices documentable and comparable for future research while avoiding premature clinical or commercial translation.

Tags

Comments

No comments yet.

Log in to comment